As of January 2023, two new members joined the Board of the SCS Division Industrial & Applied Chemistry. We are happy to welcome:

Dr. Lucie Lovelle
Novartis Pharma AG

Lucie Lovelle is a Associate Director in the Chemical and Analytical Development organization of Novartis. Lucie earned her PhD in Organic Chemistry from the University of Montreal (Canada), where she worked, under the supervision of Prof. André B. Charette, on the diastereo- and enantioselective synthesis of 1,2,3-trisubstituted cyclopropanes. In 2010, she moved to ETH Zürich (Switzerland) to complete her post-doctoral studies in the group of Prof. Ryan Gilmour, leveraging from the gauche effect to design and synthesize various fluorinated organocatalysts. Lucie was recruited a year later by Janssen, pharmaceutical companies of Johnson & Johnson (Schaffhausen, Switzerland) to work on, among other projects, the development of bedaquiline, an approved marketed drug to treat multi-drug-resistant tuberculosis (MDR-TB). Since 2015, Lucie is working at Novartis in process research & development for drug candidates across indications and phases of clinical development.

Dr. Stefan Abele
Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil, Email:  

Stefan Abele studied chemistry at the universities of Konstanz and Grenoble, did his diploma with Prof. R. R. Schmidt on carbohydrate synthesis, and received his PhD in synthetic organic chemistry at the ETH Zurich (Prof. D. Seebach) in 1999. He joined Carbogen-Amcis where he held positions of growing responsibility in R&D and GMP manufacturing of Drug Substances for pharma customers worldwide. He was involved in the GMP production of more than 80 Active Pharmaceutical Ingredients. In 2006, Stefan set up a fully integrated Chemistry Process R&D department at Actelion where he and his teams received the 2015 Sandmeyer Award. Since the inception of Idorsia in 2017, Stefan is responsible for chemical Process R&D and manufacturing from the preclinical phase to launch and global commercial supplies. As Head of Chemical Development and Commercial Manufacturing (CDCM) he is part of the Idorsia Leadership Team. Stefan is an enthusiastic chemist and actively engaged in sharing the fantastic world of process chemistry and scale-up with the scientific community.

> DIAC Portal incl. news, event announcements and contacts

David Spichiger, SCS